• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射曲安奈德治疗特发性黄斑旁毛细血管扩张症

[Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].

作者信息

Maia Otacílio Oliveira, Takahashi Walter Yukihiko, Bonanomi Maria Teresa Brizzi C, Nascimento Vinícius Paganini, Melo Carlos Sérgio Nascimento de

机构信息

Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Arq Bras Oftalmol. 2006 Nov-Dec;69(6):941-4.

PMID:17273694
Abstract

Case report of one idiopathic juxtafoveal telangiectasis (IJT) 1A patient whose right eye was treated with a 4 mg intravitreal triamcinolone acetonide injection. The outcome was evaluated by visual acuity and optic coherence tomography. The visual acuity and the caliper retinal thickness before triamcinolone injection were respectively 20/100 and 569 microm, and 20/60 and 371 microm after three weeks and 20/100 and 614 microm after six week of follow-up. The stabilization of the vascular wall due to the intravitreal triamcinolone injection leads to a transitory improvement in vision and reduction in macular edema in the TJI 1A eyes. No permanent help by the photocoagulation could be shown.

摘要

一例特发性黄斑旁毛细血管扩张症(IJT)1A患者右眼接受4毫克玻璃体内注射曲安奈德治疗的病例报告。通过视力和光学相干断层扫描评估治疗效果。注射曲安奈德前视力和卡尺测量的视网膜厚度分别为20/100和569微米,三周后为20/60和371微米,随访六周后为20/100和614微米。玻璃体内注射曲安奈德导致血管壁稳定,使TJI 1A眼的视力暂时改善,黄斑水肿减轻。未显示光凝有永久性帮助。

相似文献

1
[Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].玻璃体内注射曲安奈德治疗特发性黄斑旁毛细血管扩张症
Arq Bras Oftalmol. 2006 Nov-Dec;69(6):941-4.
2
[Triamcinolone in the treatment of the diabetic macular edema--one-year results].曲安奈德治疗糖尿病性黄斑水肿——一年期结果
Cesk Slov Oftalmol. 2008 Jul;64(4):149-52.
3
Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.玻璃体内注射曲安奈德对II型特发性黄斑旁毛细血管扩张症非增殖期的长期影响。
Retina. 2008 Feb;28(2):314-9. doi: 10.1097/IAE.0b013e31814cf03e.
4
Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis.玻璃体内注射曲安奈德治疗单侧特发性黄斑旁毛细血管扩张症
Clin Exp Ophthalmol. 2005 Oct;33(5):542-4. doi: 10.1111/j.1442-9071.2005.01081.x.
5
Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.玻璃体内注射曲安奈德治疗糖尿病性黄斑水肿后视网膜血管管径变化
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4707-11. doi: 10.1167/iovs.08-1678. Epub 2008 Jul 3.
6
Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.玻璃体内注射曲安奈德治疗有无格栅样激光光凝的视网膜分支静脉阻塞继发黄斑水肿的疗效。
Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1.
7
Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.玻璃体内注射曲安奈德治疗长期糖尿病性黄斑水肿的疗效:微视野检查和光学相干断层扫描研究
Retina. 2008 Oct;28(9):1270-5. doi: 10.1097/IAE.0b013e31817d5d1c.
8
Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.微脉冲激光光凝联合玻璃体内注射曲安奈德治疗视网膜血管瘤样增生
Retina. 2007 Nov-Dec;27(9):1201-4. doi: 10.1097/IAE.0b013e3180ed45a6.
9
Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.玻璃体内注射曲安奈德对糖尿病性黄斑水肿视网膜血管渗漏及主干血管直径的短期影响
Acta Ophthalmol Scand. 2007 Feb;85(1):21-6. doi: 10.1111/j.1600-0420.2006.00806.x.
10
Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.后Tenon囊下注射曲安奈德、玻璃体腔内注射曲安奈德及格栅样激光光凝治疗视网膜分支静脉阻塞性黄斑水肿
Ophthalmic Res. 2008;40(1):26-31. doi: 10.1159/000111155. Epub 2007 Nov 20.

引用本文的文献

1
Macular telangiectasia type 2.2 型黄斑毛细血管扩张症。
Prog Retin Eye Res. 2013 May;34:49-77. doi: 10.1016/j.preteyeres.2012.11.002. Epub 2012 Dec 3.
2
Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.非增生型 2 型特发性黄斑毛细血管扩张症的观察、玻璃体内注射贝伐单抗与经平坦部玻璃体切除术的比较。
Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1097-101. doi: 10.1007/s00417-012-2150-1. Epub 2012 Sep 6.
3
Idiopathic juxtafoveolar retinal telangiectasis: a current review.
特发性黄斑旁视网膜毛细血管扩张症:当前综述
Middle East Afr J Ophthalmol. 2010 Jul;17(3):224-41. doi: 10.4103/0974-9233.65501.
4
Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis.玻璃体内注射曲安奈德治疗特发性黄斑旁毛细血管扩张症
Oman J Ophthalmol. 2010 Jan;3(1):38-40. doi: 10.4103/0974-620X.60023.